Prostamax
Shop Prostamax on KimeraChems · code GUIDE (10% off)Definition
Prostamax, designated KEDP in research literature, is a synthetic tetrapeptide composed of four amino acids that has been investigated across multiple domains including prostate tissue protection, cellular aging, epigenetic regulation, and tissue regeneration. Unlike many peptides that rely on cell surface receptor binding, KEDP demonstrates enhanced binding efficiency to LAT1, LAT2, and PEPT1 cellular transporters, giving it access to intracellular and nuclear compartments where it exerts its regulatory effects. It has been studied most prominently in the context of chronic aseptic prostatitis, where it outperformed conventional prostatotropic agents in reducing inflammation markers and preventing the sclerotic and atrophic tissue changes associated with chronic inflammatory conditions. Its broader geroprotective profile through chromatin reactivation and epigenetic normalization adds a longevity dimension that extends well beyond prostate-specific applications.
Mechanism of Action
- Multi-transporter cellular uptake via LAT1, LAT2, and PEPT1 with molecular modeling demonstrating KEDP's negatively charged N-terminus and positively charged C-terminus enabling efficient transport across multiple cellular uptake pathways, ensuring reliable delivery to target tissues and intracellular compartments
- Anti-inflammatory pathway modulation in prostate tissue reducing markers including tissue swelling, vascular hyperemia, and lymphoid infiltration in chronic aseptic prostatitis models, operating through pathways that target underlying pathophysiology rather than masking symptoms
- Prevention of sclerotic and atrophic tissue changes interfering with the fibrotic and degenerative processes that characterize advanced chronic inflammation, preserving tissue architecture while promoting repair through modulation of inflammatory responses
- Heterochromatin modification and epigenetic regulation influencing chromatin structure in human lymphocytes to normalize age-related changes, with research suggesting these epigenetic modifications contribute to KEDP's geroprotective properties at the cellular level
- Chromatin reactivation in aging cells reversing the diminished chromatin accessibility that characterizes cellular senescence, with the tetrapeptide's influence on gene expression and protein synthesis regulation contributing to the restoration of more youthful cellular function profiles
- Aging-related gene expression normalization operating through broad regulatory mechanisms on genes involved in cellular homeostasis, growth, and stress response across tissue types
Areas of Investigation
- Prostate health and inflammation reduction with demonstrated superiority over conventional plant-based and animal-derived prostatotropic agents in experimental chronic prostatitis models, addressing both active inflammation and longer-term tissue degradation
- Prevention of prostate tissue fibrosis and atrophy by interfering with sclerotic and atrophic processes that lead to progressive functional decline in chronically inflamed prostatic tissue
- Cellular aging and geroprotective applications through chromatin reactivation and epigenetic normalization of age-related changes in lymphocyte and other cell populations, contributing to the preservation of cellular function with aging
- Tissue regeneration support with the peptide's anti-inflammatory and chromatin-modifying properties combining to promote repair processes and maintain tissue architecture in affected systems
- Efficient intracellular delivery through its multi-transporter uptake mechanism, ensuring the compound reaches the nuclear and intracellular compartments where its regulatory effects are most relevant
Safety Profile
- Favorable tolerability profile consistent with short bioregulator peptides, which are derived from naturally occurring amino acid sequences and generally well tolerated across research populations
- Limited long-term human clinical data with the majority of research conducted in experimental models, warranting a conservative and informed approach to dosing until broader human safety data becomes available
- Injection site reactions possible with subcutaneous administration, manageable with proper technique and consistent site rotation
For educational purposes only. Not for human consumption.